These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 30218759)
1. Mitochondria and neuroprotection in stroke: Cationic arginine-rich peptides (CARPs) as a novel class of mitochondria-targeted neuroprotective therapeutics. MacDougall G; Anderton RS; Mastaglia FL; Knuckey NW; Meloni BP Neurobiol Dis; 2019 Jan; 121():17-33. PubMed ID: 30218759 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Cationic Arginine-Rich Peptides (CARPs): An Assessment of Their Clinical Safety. Edwards AB; Mastaglia FL; Knuckey NW; Meloni BP Drug Saf; 2020 Oct; 43(10):957-969. PubMed ID: 32613595 [TBL] [Abstract][Full Text] [Related]
3. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage. Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120 [TBL] [Abstract][Full Text] [Related]
4. Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action. Meloni BP; Mastaglia FL; Knuckey NW Front Neurol; 2020; 11():108. PubMed ID: 32158425 [TBL] [Abstract][Full Text] [Related]
5. The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K/AKT and MAPK Pathways. Zhu H; Zhang Y; Shi Z; Lu D; Li T; Ding Y; Ruan Y; Xu A Sci Rep; 2016 May; 6():26859. PubMed ID: 27240461 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial protective effect of neferine through the modulation of nuclear factor erythroid 2-related factor 2 signalling in ischaemic stroke. Wu C; Chen J; Yang R; Duan F; Li S; Chen X Br J Pharmacol; 2019 Feb; 176(3):400-415. PubMed ID: 30414381 [TBL] [Abstract][Full Text] [Related]
7. New insights into targeting mitochondria in ischemic injury. Jia J; Jin H; Nan D; Yu W; Huang Y Apoptosis; 2021 Apr; 26(3-4):163-183. PubMed ID: 33751318 [TBL] [Abstract][Full Text] [Related]
8. Perinatal Hypoxic-Ischemic Encephalopathy and Neuroprotective Peptide Therapies: A Case for Cationic Arginine-Rich Peptides (CARPs). Edwards AB; Anderton RS; Knuckey NW; Meloni BP Brain Sci; 2018 Aug; 8(8):. PubMed ID: 30087289 [TBL] [Abstract][Full Text] [Related]
10. Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides. Chiu LS; Anderton RS; Knuckey NW; Meloni BP Mol Neurobiol; 2017 Dec; 54(10):7838-7857. PubMed ID: 27844291 [TBL] [Abstract][Full Text] [Related]
11. Poly-arginine-18 (R18) Confers Neuroprotection through Glutamate Receptor Modulation, Intracellular Calcium Reduction, and Preservation of Mitochondrial Function. MacDougall G; Anderton RS; Trimble A; Mastaglia FL; Knuckey NW; Meloni BP Molecules; 2020 Jun; 25(13):. PubMed ID: 32610439 [TBL] [Abstract][Full Text] [Related]
12. Chemical Conditioning as an Approach to Ischemic Stroke Tolerance: Mitochondria as the Target. Jin Z; Wu J; Yan LJ Int J Mol Sci; 2016 Mar; 17(3):351. PubMed ID: 27005615 [TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke. Li R; Huang Y; Chen L; Zhou H; Zhang M; Chang L; Shen H; Zhou M; Su P; Zhu D Nanomedicine; 2019 Jun; 18():380-390. PubMed ID: 30428334 [TBL] [Abstract][Full Text] [Related]
15. Estrogens as protectants of the neurovascular unit against ischemic stroke. Yang SH; Liu R; Perez EJ; Wang X; Simpkins JW Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):169-77. PubMed ID: 15857302 [TBL] [Abstract][Full Text] [Related]
16. Neurotherapeutic potential of kolaviron on neurotransmitter dysregulation, excitotoxicity, mitochondrial electron transport chain dysfunction and redox imbalance in 2-VO brain ischemia/reperfusion injury. Ojo OB; Amoo ZA; Saliu IO; Olaleye MT; Farombi EO; Akinmoladun AC Biomed Pharmacother; 2019 Mar; 111():859-872. PubMed ID: 30841465 [TBL] [Abstract][Full Text] [Related]
17. Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies. Broussalis E; Trinka E; Killer M; Harrer A; McCoy M; Kraus J Drug Discov Today; 2012 Jul; 17(13-14):671-84. PubMed ID: 22405898 [TBL] [Abstract][Full Text] [Related]
18. Intravenous Treatment with a Long-Chain Omega-3 Lipid Emulsion Provides Neuroprotection in a Murine Model of Ischemic Stroke - A Pilot Study. Berressem D; Koch K; Franke N; Klein J; Eckert GP PLoS One; 2016; 11(11):e0167329. PubMed ID: 27902774 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Peptides and New Strategies for Ischemic Stroke Drug Discoveries. Dergunova LV; Filippenkov IB; Limborska SA; Myasoedov NF Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239313 [TBL] [Abstract][Full Text] [Related]
20. Genistein: mechanisms of action for a pleiotropic neuroprotective agent in stroke. Schreihofer DA; Oppong-Gyebi A Nutr Neurosci; 2019 Jun; 22(6):375-391. PubMed ID: 29063799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]